About Us

Biography - Michael Shore, MD, DFASAM

ShoreMichael-www

Dr. Shore completed his Medical training at Temple University Medical School in Philadelphia in 1980. He then attended Thomas Jefferson University and completed his 4 year general adult training in Psychiatry in 1984, serving as Chief Resident in his final year. Following two years as an attending at Jefferson, serving as director of the acute inpatient Unit and Acting Director of the Crises Center, he joined his wife and they both completed 4 years in the National Health Service Corps with the Indian Health Service in Arizona. From 1990 through 2002 Dr. Shore worked in various venues, including Director of the Inpatient Unit at Cooper University Hospital in Camden, NJ; Residency training director for Psychiatry at Cooper; Medical Director of the Malvern Institute, a drug and alcohol treatment facility; Chief of Substance Abuse Services at Hampton Hospital; and part time work in outpatient chemical dependency treatment programs at Rancocas Hospital and with Princeton House. Dr. Shore has maintained an outpatient private practice of Psychiatry and Addiction Medicine since 1993, and has been full time in his private practice since 2002. He also serves as the Medical Director for both Elm Lifelines, a women’s IOP program, and Lakeside Recovery Center in Sicklerville, NJ. Dr. Shore has received several “Top Doc” awards for South Jersey in Psychiatry and Addiction Medicine, including most recently in 2015. Dr. Shore was honored as the Addiction Medicine Physician of the Year for 2012 by New Jersey Society of Addiction Medicine. Dr. Shore currently holds the position of President of the NJ Society of Addiction Medicine. He was elected in 2015 as the Senior Vice President of the NJ Psychiatric Association and is the Chair of the NJPA Committee on Education. He also continues to serve on the NJPA Council on Advocacy. He was appointed to the NJ Psychiatric Association as a Trustee in 2013.

Dr. Shore has organized and chaired two CME programs jointly sponsored by NJPA and NJSAM, including “Buprenorphine 201 – Advanced Topics” in 2012, and most recently “Addiction Medicine 2014 – Hot Topics” in 2014.

Disclosure of Interests and Affiliations